Ling, S., Dexter, A., Race, A. M., Sharma, S., Hamm, G., Polanska, U. M., . . . Barry, S. T. (2025, February). Use of metabolic imaging to monitor heterogeneity of tumour response following therapeutic mTORC1/2 pathway inhibition. Disease Models & Mechanisms.
Chicago Style (17th ed.) CitationLing, Stephanie, et al. "Use of Metabolic Imaging to Monitor Heterogeneity of Tumour Response Following Therapeutic MTORC1/2 Pathway Inhibition." Disease Models & Mechanisms Feb. 2025.
MLA (9th ed.) CitationLing, Stephanie, et al. "Use of Metabolic Imaging to Monitor Heterogeneity of Tumour Response Following Therapeutic MTORC1/2 Pathway Inhibition." Disease Models & Mechanisms, Feb. 2025.
Warning: These citations may not always be 100% accurate.
